Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:563 (6 September), doi:10.1136/bmj.327.7414.563-b
| The first 150 words of the full text of this article appear below. |
EDITORI fully support the use of risk stratified mortality data in preference to crude mortality data if surgeon specific comparisons are to be published. The quality of such information depends on the rigour with which data are collected. Bridgewater et al took great care to ensure completeness and accuracy of data, including prospective collection of data, such that only 2% of data were missing. This adds considerable weight to their conclusions.1
If such methods are to be used nationally, there must be equally robust validation of the data collection process in all institutions to prevent potential information bias. There is a danger that data will be collected retrospectively, and the investment in, and quality of, coding and record keeping varies greatly between institutions. For example, the absence of data on comorbidities or the failure to code them will result in a low estimate of expected mortality and falsely
David R Walker, director of public health
County Durham and Tees Valley Strategic Health Authority, Teesdale House, Stockton on Tees TS17 6BL david.walker@cdtvha.nhs.uk